For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Blog
State Directed Payments redistribute money across states and supercharged growth
Differences in states’ use of SDPs cause an interstate redistribution of taxes as well. Because states are setting different levels of SDPs, spending varies…
Search Posts
Op-Eds
Noisy Spring: Avoiding the West Nile virus
The six-year-old U.S. outbreak of West Nile virus is a significant threat to public health and shows no signs of abating. Last year, there were…
Op-Eds
Pesticides Not a Threat to Students
The anti-pesticide crowd tried to scare parents last week with a new report alleging that pesticide use in schools is dangerous for students.
Citation
Small Tobacco Brands Hit by Payments
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. HEALTH & SAFETY A new study raises concerns about the health effects on children of pesticides…
Newsletter
The Competitive Enterprise Institute Daily Update
1. BUDGET The highway bill currently before Congress is igniting the wrath of fiscal conservatives for being loaded with spending for questionable…
Bond Buyer